Abstract This study was designed to evaluate the combined effects of bacteriophage and antibiotic on the reduction of the development of antibiotic-resistance in Salmonella typhimurium LT2. The susceptibilities of S. typhimurium to ciprofloxacin and erythromycin were increased when treated with bacteriophages, showing more than 10% increase in clear zone sizes and greater than twofold decrease in minimum inhibitory concentration values. The growth of S. typhimurium was effectively inhibited by the combination of bacteriophage P22 and ciprofloxacin. The combination treatment effectively reduced the development of antibiotic resistance in S. typhimurium. The relative expression levels of efflux pump-related genes (acrA, acrB, and tolC) and outer membrane-related genes (ompC, ompD, and ompF) were decreased at all treatments. This study provides useful information for designing new antibiotic therapy to control antibiotic-resistant bacteria.
Introduction
Non-typhoidal Salmonella typhimurium and S. Enteritidis, are the most common pathogenic serovars that can cause gastroenteritis, enteric fever, infectious diarrheal, and septicemia [1] . Non-typhoidal Salmonella infections remain a serious public health problem worldwide, which resulted in approximately 94 million cases and 155,000 deaths annually [2] . Furthermore, non-typhoidal Salmonella serovars represent a reservoir of antibiotic resistance determinants [16] . This is responsible for the acquisition of multiple antibiotic resistance to b-lactams, fluoroquinolones, and tetracycline in non-typhoidal Salmonella serovars [7, 15] . The mechanisms of antibiotic resistance include enzymatic degradation of antibiotics, activation in efflux pump systems, and alteration in membrane permeability [8, 17] . The emergence and dissemination of antibiotic-resistant Salmonella have become a major problem in a clinical and hospital setting due to the frequent failure in antibiotic treatments [25] . Therefore, the novel approach to improving current antibiotic use is essential for control of antibiotic-resistant bacterial infections.
Recently, bacteriophage has been renewed attention as an alternative approach for treatment of bacterial infections due to its effective specificity to target bacteria [3] . Bacteriophages can recognize the bacterial cell surface-exposed receptors such as pili, flagella, capsule, membrane proteins, and lipopolysaccharides [26, 31] . Recent studies have reported the effectiveness of using bacteriophages in combating against bacterial pathogens, including bacteriophage cocktails and bacteriophage-antibiotic combinations [9, 23, 29, 30] . Most researches highlights that the application of bacteriophages can be a promising strategy to overcoming antibiotic resistance. However, relatively few studies have evaluated the bacteriophage resistance mechanisms when bacteria are exposed to selective pressure. Therefore, the objective of this study was to investigate the efficiency of bacteriophage-antibiotic combination against S. typhimurium and also evaluate bacterial resistance to bacteriophage.
Materials and methods

Bacterial strains and culture conditions
Strain of Salmonella enterica subsp. enterica serovar typhimurium LT2 (ATCC 19585) was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in trypticase soy broth (TSB) (BD, Becton, Dickinson and Co., Sparks, MD, USA) at 37°C for 20 h. The cultured cells were centrifuged at 30009g for 20 min at 4°C. The collected cells diluted with phosphatebuffered saline (PBS, pH 7.2) to 10 8 CFU/ml.
Bacteriophage propagation and enumeration
Salmonella bacteriophage P22 (ATCC 97541) was propagated at 37°C for 24 h in TSB containing S. typhimurium as a suggested host. The propagated phages were harvested by centrifugation at 50009g for 10 min. The harvested phages were filtered through a 0.2-lm filter to eliminate bacterial lysates. The phage titers were determined by using the double agar overlay plaque assay [4] . In brief, phages were diluted with PBS. The diluted phages were mixed with TSB (0.5% agar) containing the host cells (10 7 CFU/ml) and then poured onto the agar lawn plates. The soft-agar overlaid plates were incubated at 37°C for 24 h to count the phages which were expressed as plaqueforming unit (PFU).
Agar diffusion test
The disk diffusion susceptibility was measured to determine the synergistic effect of phage P22 and antibiotic. The Muller-Hinton agar plates containing S. typhimurium (10 5 CFU/ml) were prepared without and with phage P22 (10 5 PFU/ml). The antibiotic disks, including cefotaxime (30 lg), chloramphenicol (30 lg), ciprofloxacin (5 lg), erythromycin (15 lg), streptomycin (10 lg), and tetracycline (30 lg), were placed on the prepared Muller-Hinton agar plates and then incubated at 37°C for 18 h. After incubation, the diameters of the zone of inhibition were measured in centimeters using a digital vernier caliper (The L.S. Starrett Co., Athol, MA, USA).
Preparation of antibiotic stock solutions
All antibiotics used in this study were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The stock solutions of cefotaxime in water, chloramphenicol in absolute ethanol, ciprofloxacin in glacial acetic acid, erythromycin in absolute ethanol, streptomycin in water, and tetracycline in absolute ethanol were prepared at a concentration of 1024 mg/ml. The antibiotic working solutions were freshly prepared prior to use.
Antibiotic susceptibility assay
The susceptibility of S. typhimurium to each antibiotic was evaluated in the absence and presence of phage P22. S. typhimurium (10 5 CFU/ml) was inoculated in 96-well microtiter plates containing twofold serial dilution of each antibiotic (cefotaxime, chloramphenicol, ciprofloxacin, erythromycin, streptomycin, or tetracycline) without and with phage P22. The inoculated 96-well plates were incubated for 18 h at 37°C. The growth of S. typhimurium was observed at 600 nm [13] and fitted to exponential function using Microcal Origin Ò 8.0 (Microcal Software Inc., Northampton, MA, USA).
Time-kill curve analysis
The inhibitory effects of phage P22, ciprofloxacin, and combination against S. typhimurium was evaluated by the time-kill assay. Phage P22 (10 5 PFU/mL), ciprofloxacin (1 9 MIC; 0.016 lg/mL), and combination were inoculated with S. typhimurium (10 5 CFU/mL) in TSB. Each treatment was cultured for 20 h at 37°C. The growth of S. typhimurium was measured at every 4-h interval. After 20-h culture, samples were collected for the analyses of antibiotic resistance and gene expression.
Antibiotic resistance profile
The changes in antibiotic resistance phenotype after the time-kill assay were estimated by using a disk diffusion assay. S. typhimurium cells cultured in the control, phage P22 alone, ciprofloxacin alone, and combination were streaked onto Muller-Hinton agar plate. The antibiotic disks (cefotaxime, chloramphenicol, ciprofloxacin, erythromycin, streptomycin, and tetracycline) were placed on the prepared Muller-Hinton agar plates and incubated at 37°C for 18 h. After incubation, the antibiotic susceptibility was compared by measuring the diameters of clear zone.
Quantitative PCR assay
Total RNA from S. typhimurium cells cultured in the control, phage P22 alone, ciprofloxacin alone, and combination was extracted according to the protocol of RNeasy Protect Bacteria Mini kit (Qiagen, Hilden, Germany), and then cDNA was synthesized according to the QuantiTech reverse transcription procedure (Qiagen). For qPCR assay, the reaction mixture (10 ll of 2 9 QuantiTect SYBR Green PCR Master, 2 ll of each primer (Table 1) 
Statistical analysis
All experiments were conducted in duplicate for three replicates. Data were analyzed using the Statistical Analysis System software. The general linear model and Fisher's least significant difference procedures were used to determine significant mean differences at P \ 0.05.
Results and discussion
Antibiotic susceptibility patterns of S. typhimurium in the presence of phages
The antibiotic susceptibility of S. typhimurium LT2 was evaluated in the absence and presence of phage P22 using disk diffusion assay ( Table 2 ). The clear zone sizes of cefotaxime, chloramphenicol, ciprofloxacin, erythromycin, streptomycin, and tetracycline disks were increased to 13, 10, 22, 25, 9, and 12%, respectively, in the presence of phage P22. The growth of phages was stimulated by antibiotics [6] , leading to the enhanced lysis of host bacterium, S. typhimurium LT2. This result is a good agreement with previous report that the increased plaque size and phage titer were observed after antibiotic treatment [10] . The MIC values of antibiotics against S. typhimurium LT2 were evaluated in the absence of presence of phage P22 (Fig. 1) . The antibiotic susceptibilities of LT2 were noticeably increased in the presence of phage P22 compared to the absence of phage P22, showing more than twofold decrease in MIC values; cefotaxime (0.06-0.03 lg/mL), chloramphenicol (4-0.25 lg/mL), ciprofloxacin (0.016-0.008 lg/mL), erythromycin (64-8 lg/mL), streptomycin (64-16 lg/mL), and tetracycline (2-1 lg/mL). The decreased MIC values in S. typhimurium LT2 treated with combination might be due to the changes in permeability and efflux pump activity [18] . Antibiotics play an important role in the increased burst size and reduced latent period of phages, leading to an increase in the susceptibility of bacteria [29] . However, antibiotics can interfere with the phage replication within bacteria cells, resulting in the reduction in the phage- antibiotic combination effect [5] . Therefore, further studies are needed to understand the mechanisms of phage-host interplay and antibiotic resistance for phage-antibioticbased therapeutic approach.
Combined inhibitory effect of phage and ciprofloxacin on the growth of S. typhimurium
The antimicrobial effect of phage P22 alone, ciprofloxacin alone, and combination against S. typhimurium LT2 was evaluated at 37°C for 20 h (Fig. 2) . Ciprofloxacin was used to evaluate the induction of antibiotic resistance, representing the second generation of fluoroquinolone.
Compared to the control, the growth of S. typhimurium LT2 was significantly inhibited by all treatments throughout the incubation. The most considerable reduction was observed for the combination treatment, resulting in more than 5-log reduction up to 12-h of incubation. However, the number of S. typhimurium LT2 treated with phage P22 was increased after 12-h incubation. This might be due to the presence of bacterial cells resistant to bacteriophage P22 [12] . The ability of develop resistance to antibiotics was evaluated in S. typhimurium LT2 treated with phage P22, ciprofloxacin, and combination after 20-h incubation (Fig. 3) . The antibiotic susceptibilities varied in the treatments. Compared to the control, the enhanced susceptibilities of S. typhimurium LT2 to erythromycin, streptomycin, and tetracycline were observed at the combination treatment, while S. typhimurium LT2 treated with phage P22 alone and antibiotic alone was less sensitive to erythromycin and streptomycin. The results suggest that appropriate antibiotic use can improve the antimicrobial activity when combined with phages. The phage-antibiotic combination can be possibly used to reduce the resistance to phages and antibiotics [19, 22] .
Differential gene expression of S. typhimurium treated with phage, ciprofloxacin, and combination
The relative expression of efflux pump-related genes (acrA, acrB, and tolC) and outer membrane-related genes (ompC, Means with different letters (a-e) within a column are significantly different at P \ 0.05 and means with different letters (A-B) within a row are significantly different at P \ 0.05 Fig. 1 Antibiotic susceptibility of S. typhimurium in the absence (opened circle) and presence (filled circle) of bacteriophages ompD, and ompF) was observed in S. typhimurium LT2 treated with phage P22 alone, antibiotic alone, and combination, compared to the control (Fig. 4) . The relative expression levels of genes used in this study were decreased at all treatments. The antibiotic resistance in bacteria is associated with the efflux pump systems, including ATP-binding cassette (ABC), major facilitator (MF), small multidrug resistance (SMR), multidrug and toxic compound extrusion (MATE), and resistancenodulation-cell division (RND) [20] . The tripartite efflux transporter complex, AcrAB-TolC, is mainly responsible for the antibiotic resistance in S. typhimurium, which has a broad specificity to various substrates such as b-lactams, fluoroquinolones, tetracycline, and erythromycin [11, 27] . In structure, AcrA, AcrB, and TolC are located in the periplasmic protein, the inner membrane, and the outer membrane, respectively [21] . The downregulation of efflux pump-related genes (acrA, acrB, and tolC) and outer membrane-related genes (ompC, ompD, and ompF) are responsible for the reduced permeability and efflux of antibiotics, leading to the increase in the antibiotic susceptibility of S. typhimurium LT2 [18, 24, 28] . Moreover, the decrease in AcrAB-TolC leads to reduce the virulence of Salmonella because acrA, acrB, and tolC are required for efficient adhesion invasion of epithelial cells and macrophages [32] . Phage combined with antibiotic, known as phage-antibiotic synergy (PAS), can be an alternative way to control bacterial infections. PAS can also be a possible strategy for reducing the emergence of phage-resistant mutants [22] .
In conclusion, the significant findings are that the antibiotic susceptibility of S. typhimurium LT2 was significantly increased when combined with phages and the growth of S. typhimurium LT2 was synergistically inhibited by the combination of phage P22 and antibiotic. The combined treatment of phage P22 and ciprofloxacin could downregulate the expression of efflux pump-related genes (acrA, acrB, and tolC) and outer membrane-related genes (ompC, ompD, and ompF), resulting in the increased antibiotic susceptibility of S. typhimurium LT2. These results highlight the advantages of using phage-antibiotic combination to prevent the emergence of antibiotic resistant strains. 
